logo
Select company
Select metric
0%Goodwill & Intangibles to Assets Ratio
VS
Market
-
Sector
-
Industry
-
History
-
$ 59.38Close
$ 7.36 - $ 62.99 52-Week Range
Ticker Information

Ticker

NKTR

Company Name

NEKTAR THERAPEUTICS

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

NEKTAR THERAPEUTICS - Goodwill & Intangibles to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

NKTR - Intang. to Assets Historical data
DateTotal AssetsGoodwill and IntangiblesGoodwill & Intangibles to Assets Ratio
6/30/2025$ 207.53M$ 00%
3/31/2025$ 256.24M$ 00%
12/31/2024$ 303.85M$ 00%
9/30/2024$ 307.97M$ 00%
6/30/2024$ 343.33M$ 00%
3/31/2024$ 396.01M$ 00%
12/31/2023$ 398.03M$ 00%
9/30/2023$ 442.24M$ 00%
6/30/2023$ 494.28M$ 00%
3/31/2023$ 561.74M$ 00%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • NEKTAR THERAPEUTICS's latest trailing twelve months (TTM) Intang. to Assets stands at 5.07%.
  • Over the past 5 years, NEKTAR THERAPEUTICS's average Intang. to Assets has been 3.53%.
  • The median Intang. to Assets for NEKTAR THERAPEUTICS during this period was 2.49%
  • NEKTAR THERAPEUTICS reached its highest Intang. to Assets over the past 5 years at 10.77%.
  • The lowest Intang. to Assets recorded by NEKTAR THERAPEUTICS in the same timeframe 0%

NEKTAR THERAPEUTICS's Intang. to Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Intang. to Assets Benchmarks
CompanyIntang. to Assets
YMAB : Y-MABS THERAPEUTICS INC 1.86%LXRX : LEXICON PHARMACEUTICALS INC 19.75%ADCT : ADC THERAPEUTICS SA 0%KURA : KURA ONCOLOGY INC 0%SAGE : SAGE THERAPEUTICS INC 0%TBPH : THERAVANCE BIOPHARMA INC 0%TRDA : ENTRADA THERAPEUTICS INC 0%XOMA : XOMA ROYALTY CORP 20.33%GOSS : GOSSAMER BIO INC 0%CDXS : CODEXIS INC 1.78%

Definition of Goodwill & Intangibles to Assets Ratio

[Calculation] The [Intangibles] to [Assets] ratio is used as a company valuation factor by investors. Goodwill & Intangibles represent hard-to-value assets like a company’s brand name, solid customer relations, intellectual property, etc.
Intangibles / Assets
(=) Intang. to Assets
Intang. to Assets for NEKTAR THERAPEUTICS is calculated as follows: Intangibles [ $ 76.5M ] / Assets [ $ 1.51B ]
(=) Intang. to Assets [ 5.07% ]

NKTR - Goodwill & Intangibles to Assets Ratio, Last 5 years

0%

Minimum

Mar 31, 2023

10.77%

Maximum

Dec 31, 2022

3.53%

Average

2.49%

Median

Intang. to Assets Benchmark Analysis

The chart above depicts the distribution of Intang. to Assets for companies in the Total Stock Market. The average Intang. to Assets of the companies is 3.99% with a standard deviation of 6.1%.
The following table provides additional summary stats:
Intang. to Assets in the Market:
filtered constituents3.24K
min0%
max23.21%
average3.99%
median0.52%
std6.1%